Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations

BACKGROUND: IPX066 is an extended-release (ER) oral formulation of carbidopa-levodopa (CD-LD). Following an initial peak at about one hour, plasma LD concentrations are maintained for about 4-5 hours. OBJECTIVE: To present dosing factors that may affect the successful conversion to ER CD-LD from oth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Parkinsons Dis
Main Authors: Morgan, John C., Dhall, Rohit, Rubens, Robert, Khanna, Sarita, Gupta, Suneel
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217748/
https://ncbi.nlm.nih.gov/pubmed/30425824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9763057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados